X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11) 11
aged (10) 10
male (10) 10
middle aged (10) 10
female (9) 9
abridged index medicus (7) 7
index medicus (7) 7
medicine, general & internal (7) 7
adult (6) 6
cardiovascular disease (6) 6
risk factors (6) 6
cholesterol (5) 5
patients (5) 5
safety (5) 5
statins (5) 5
cardiovascular diseases (4) 4
coronary-heart-disease (4) 4
double-blind method (4) 4
events (4) 4
metaanalysis (4) 4
randomized controlled trials as topic (4) 4
studies (4) 4
treatment outcome (4) 4
anticholesteremic agents - therapeutic use (3) 3
cardiovascular diseases - prevention & control (3) 3
cholesterol, ldl - blood (3) 3
clinical trials (3) 3
diabetes (3) 3
efficacy (3) 3
follow-up studies (3) 3
health risk assessment (3) 3
health risks (3) 3
heart attacks (3) 3
high-dose atorvastatin (3) 3
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (3) 3
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (3) 3
hypercholesterolemia - drug therapy (3) 3
internal medicine (3) 3
low density lipoprotein (3) 3
low density lipoproteins (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
mortality (3) 3
myocardial infarction (3) 3
outcomes (3) 3
pravastatin (3) 3
prevention (3) 3
primary prevention (3) 3
simvastatin (3) 3
simvastatin - adverse effects (3) 3
stroke (3) 3
therapy (3) 3
triglycerides (3) 3
aged, 80 and over (2) 2
anticholesteremic agents - adverse effects (2) 2
atorvastatin (2) 2
average (2) 2
biomarkers - blood (2) 2
blood cholesterol (2) 2
blood pressure (2) 2
cancer (2) 2
cardiac & cardiovascular systems (2) 2
cardiovascular diseases - blood (2) 2
cardiovascular diseases - drug therapy (2) 2
cholesterol, ldl (2) 2
cholesterol, ldl - drug effects (2) 2
clinical medicine (2) 2
coronary artery disease (2) 2
dose-response relationship, drug (2) 2
drug therapy (2) 2
ezetimibe (2) 2
heart diseases (2) 2
heart failure (2) 2
heart-disease (2) 2
hemodialysis (2) 2
hypercholesterolemia (2) 2
incidence (2) 2
laboratories (2) 2
lipids (2) 2
lipoproteins (2) 2
low-density-lipoprotein (2) 2
medical research (2) 2
meta-analysis (2) 2
research (2) 2
risk assessment (2) 2
simvastatin - therapeutic use (2) 2
11 medical and health sciences (1) 1
abnormalities (1) 1
acute coronary syndromes (1) 1
acute disease (1) 1
adiponectin (1) 1
administration, sublingual (1) 1
adolescent (1) 1
age distribution (1) 1
age factors (1) 1
alirocumab (1) 1
allergens (1) 1
allergens - administration & dosage (1) 1
allergic reaction (1) 1
allergies (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9716, pp. 735 - 742
Journal Article
The Lancet, ISSN 0140-6736, 08/2004, Volume 364, Issue 9436, pp. 771 - 777
Journal Article
The Lancet, ISSN 0140-6736, 10/2017, Volume 390, Issue 10106, pp. 1962 - 1971
Journal Article
The Lancet, ISSN 0140-6736, 10/2018, Volume 392, Issue 10155, pp. 1311 - 1320
Background: Elevated lipoprotein(a) is a genetic risk factor for cardiovascular disease in general population studies. However, its contribution to risk for... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | SERIES-LIPOPROTEIN | MYOCARDIAL-INFARCTION | TARGETING APOLIPOPROTEIN(A) | AORTIC-STENOSIS | DOUBLE-BLIND | ACUTE CORONARY SYNDROMES | OXIDIZED PHOSPHOLIPIDS | TYPE-2 DIABETES-MELLITUS | PRIMARY PREVENTION | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Male | Biomarkers - blood | Hypercholesterolemia - drug therapy | Randomized Controlled Trials as Topic | Lipoprotein(a) - drug effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cardiovascular Diseases - blood | Cardiovascular Diseases - epidemiology | Cholesterol, HDL - blood | Cholesterol, LDL - blood | Female | Aged | Lipoprotein(a) - blood | Medical research | Care and treatment | Patient outcomes | Low density lipoproteins | Coronary heart disease | Lipoprotein A | Risk factors | Cardiovascular agents | Blood cholesterol | Analysis | Cardiac patients | Medicine, Experimental | Statins | Lipoproteins (low density) | Therapy | Clinical trials | Cardiovascular disease | Population studies | Blood pressure | Heart diseases | Lipoproteins (high density) | Data analysis | Stroke | Medical treatment | Diabetes mellitus | Health risks | Data processing | Risk analysis | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Studies | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Smoking | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
by Swerdlow, Daniel I, Dr and Preiss, David, Dr and Kuchenbaecker, Karoline B, MSc and Holmes, Michael V, PhD and Engmann, Jorgen E L, MSc and Shah, Tina, PhD and Sofat, Reecha, MD and Stender, Stefan, MD and Johnson, Paul C D, PhD and Scott, Robert A, PhD and Leusink, Maarten, MSc and Verweij, Niek, MD and Sharp, Stephen J, MSc and Guo, Yiran, PhD and Giambartolomei, Claudia, MSc and Chung, Christina, MSc and Peasey, Anne, PhD and Amuzu, Antoinette, MSc and Li, KaWah, MSc and Palmen, Jutta, MSc and Howard, Philip, MSc and Cooper, Jackie A, MSc and Drenos, Fotios, PhD and Li, Yun R, BSc and Lowe, Gordon, Prof and Gallacher, John, PhD and Stewart, Marlene C W, PhD and Tzoulaki, Ioanna, PhD and Buxbaum, Sarah G, PhD and van der A, Daphne L, PhD and Forouhi, Nita G, MRCP and Onland-Moret, N Charlotte, PhD and van der Schouw, Yvonne T, Prof and Schnabel, Renate B, MD and Hubacek, Jaroslav A, PhD and Kubinova, Ruzena, MD and Baceviciene, Migle, MD and Tamosiunas, Abdonas, Prof and Pajak, Andrzej, Prof and Topor-Madry, Romanvan, MD and Stepaniak, Urszula, PhD and Malyutina, Sofia, Prof and Baldassarre, Damiano, PhD and Sennblad, Bengt, PhD and Tremoli, Elena, Prof and de Faire, Ulf, Prof and Veglia, Fabrizio, PhD and Ford, Ian, Prof and Jukema, J Wouter, Prof and Westendorp, Rudi G J, Prof and de Borst, Gert Jan, MD and de Jong, Pim A, MD and Algra, Ale, Prof and Spiering, Wilko, MD and der Zee, Anke H Maitland-van, PhD and Klungel, Olaf H, PharmD and de Boer, Anthonius, Prof and Doevendans, Pieter A, Prof and Eaton, Charles B, Prof and Robinson, Jennifer G, Prof and Duggan, David, PhD and Kjekshus, John, Prof and Downs, John R, MD and Gotto, Antonio M, MD and Keech, Anthony C, MD and Marchioli, Roberto, MD and Tognoni, Gianni, MD and Sever, Peter S, Prof and Poulter, Neil R, Prof and Waters, David D, MD and Pedersen, Terje R, MD and Amarenco, Pierre, MD and Nakamura, Haruo, MD and McMurray, John J V, Prof and Lewsey, James D, PhD and Chasman, Daniel I, PhD and Ridker, Paul M, MD and Maggioni, Aldo P, Prof and Tavazzi, Luigi, Prof and Ray, Kausik K, Prof and Seshasai, Sreenivasa Rao Kondapally, MD and Manson, JoAnn E, Prof and Price, Jackie F, MD and Whincup, Peter H, Prof and Morris, Richard W, Prof and Lawlor, Debbie A, Prof and Smith, George Davey, Prof and Ben-Shlomo, Yoav, Prof and Schreiner, Pamela J, Prof and Fornage, Myriam, Prof and Siscovick, David S, Prof and Cushman, Mary, MD and Kumari, Meena, PhD and Wareham, Nick J, Prof and Verschuren, W M Monique, PhD and Redline, Susan, Prof and Patel, Sanjay R, MD and Whittaker, John C, Prof and Hamsten, Anders, Prof and Delaney, Joseph A, PhD and ... and MAGIC Consortium and InterAct Consortium and DIAGRAM Consortium
The Lancet, ISSN 0140-6736, 01/2015, Volume 385, Issue 9965, pp. 351 - 361
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9784, pp. 2181 - 2192
Summary Background Lowering LDL cholesterol with statin regimens reduces the risk of myocardial infarction, ischaemic stroke, and the need for coronary... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | UNITED-KINGDOM HEART | DESIGN | METAANALYSIS | REQUIRING PROLONGED OBSERVATION | EFFICACY | CARDIOVASCULAR EVENTS | SAFETY | HEMODIALYSIS | OUTCOMES | PARTICIPANTS | Confidence Intervals | Simvastatin - adverse effects | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Ezetimibe | Renal Dialysis - methods | Male | Reference Values | Cholesterol, LDL - analysis | Kidney Function Tests | Renal Insufficiency, Chronic - drug therapy | Dose-Response Relationship, Drug | Renal Insufficiency, Chronic - therapy | Renal Dialysis - mortality | Time Factors | Renal Insufficiency, Chronic - mortality | Adult | Female | Renal Insufficiency, Chronic - diagnosis | Drug Therapy, Combination | Severity of Illness Index | Hypolipidemic Agents - adverse effects | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Simvastatin - administration & dosage | Cholesterol, LDL - drug effects | Treatment Outcome | Azetidines - administration & dosage | Hypolipidemic Agents - administration & dosage | Survival Analysis | Aged | Simvastatin | Low density lipoproteins | Physiological aspects | Drug therapy, Combination | Research | Kidney diseases | Diagnosis | Drug therapy | Health aspects | Studies | Heart failure | Cardiac arrhythmia | Medical imaging | Hospitals | Compliance | Cardiovascular disease | Blood pressure | Family medical history | Cholesterol | Cancer | Mortality | myocardial infarction | cholesterol | councils | Dialysis | medical research | stroke | Kidney | Fast track | Pharmaceutical Sciences | Basic Medicine | PHARMACY | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | FARMACI | Farmaceutiska vetenskaper
Journal Article